DUJ-29304-87318
2 vaccinations
7 coded responses
9 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 782 / TX
- Registered
- 2021-09-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-10
Dose 1 — Pfizer-BioNTech
-
2021-09-11
Registered in v-safe
-
2021-09-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-13
Survey response — days 1–6 daily, dose 1MedDRA: Abnormal dreams, Decreased appetite, Insomnia, Middle insomnia — Feeling: Poor · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Insomnia, vivid dreams, frequent waking during the night, lack of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-09-14
Survey response — days 1–6 daily, dose 1MedDRA: Abnormal dreams, Insomnia, Middle insomnia, Nightmare — Feeling: Fair · Site: Redness, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Insomnia, nightmares/vivid dreams, frequent waking during the nightMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Survey response — days 1–6 daily, dose 1MedDRA: Back pain, Flank pain — Feeling: Fair · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Intermittent stabbing pain in side & lower backMedDRA releases: 2024-11 · check-in free text available
-
2021-09-16
Survey response — days 1–6 daily, dose 1MedDRA: Dysgeusia, Flank pain — Feeling: Fair · Nausea, Abdominal painFree text: Intermittent pains in side and flank, sudden strong metallic tasteMedDRA releases: 2024-11 · check-in free text available
- 2021-09-17
-
2022-01-13
Dose 2 — Pfizer-BioNTech
-
2022-01-13
Survey response — day 0, dose 2MedDRA: Rash, Rash macular — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Rash, not including the immediate area around the injection siteFree text: Blotchy disemminated flat rash all over my bodyMedDRA releases: 2024-11 · check-in free text available
-
2022-01-14
Survey response — days 1–6 daily, dose 2MedDRA: Rash — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Diffuse lacey rash on legs and armsMedDRA releases: 2024-11 · check-in free text available
-
2022-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Dysmenorrhoea, Heavy menstrual bleeding, Menstruation irregular — Feeling: Poor · Muscle or body aches · Be unable to do your normal daily activitiesFree text: I started my period today, which is a full week early. The first date of my last menstrual cycle was December 25th. I am experiencing menstrual pain at an 8/10, and I am experiencing a much heavier flow than normal. The pain started last night..MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-10 | Pfizer-BioNTech | No |
| 2 | 2022-01-13 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Insomnia, vivid dreams, frequent waking during the night, lack of appetite
Systemic reaction (other): Insomnia, nightmares/vivid dreams, frequent waking during the night
Systemic reaction (other): Intermittent stabbing pain in side & lower back
Systemic reaction (other): Intermittent pains in side and flank, sudden strong metallic taste
Release 10 — day 0, dose 2
Systemic reaction (other): Blotchy disemminated flat rash all over my body
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Diffuse lacey rash on legs and arms
Systemic reaction (other): I started my period today, which is a full week early. The first date of my last menstrual cycle was December 25th. I am experiencing menstrual pain at an 8/10, and I am experiencing a much heavier flow than normal. The pain started last night..
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Abnormal dreams | · | · | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Dysgeusia | · | · | ✓ |
| SRO | Dysmenorrhoea | · | · | ✓ |
| SRO | Flank pain | · | · | ✓ |
| SRO | Heavy menstrual bleeding | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Menstruation irregular | · | · | ✓ |
| SRO | Middle insomnia | · | · | ✓ |
| SRO | Nightmare | · | · | ✓ |
| SRO | Rash | · | · | ✓ |
| SRO | Rash macular | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release